- Home>
- Specialty Care>
- Oncology and Hematology>
- About>
- Disclosure Information
Disclosure Information
The editors of Journal Watch Oncology and Hematology have disclosed the following information in keeping with the conflict of interest policy of the MMS Professional Newsletters:
William J. Gradishar, MD, Editor-in-Chief
- Consultant / Advisory board
-
- Abraxis BioScience Inc.; AstraZeneca; Bristol-Myers Squibb; Genentech; Genomic Health; GlaxoSmithKline; Novartis; Pfizer; sanofi-aventis
- Speaker's bureau
-
- Abraxis BioSciene Inc.; AstraZeneca; Bristol-Myers Squibb; Genentech; Genomic Health; Novartis; Pfizer
- Grant / research support
-
- Various clinical trials
- Editorial boards
-
- Clinical Breast Cancer; Oncology
- Leadership positions in professional societies
-
- American College of Surgeons Commission on Cancer (Executive Committee); Association of Subspecialty Professors (Board Member)
Robert Dreicer, MD, MS, FACP, Associate Editor
- Consultant / Advisory board
-
- Bristol-Myers Squibb; Eli Lilly; MedImmune; Merck; Pfizer
- Speaker's bureau
-
- Berlex; sanofi-aventis
- Grant / research support
-
- American BioScience; Berlex; Celgene; Eli Lilly
- Editorial boards
-
- Journal of Clinical Oncology; Journal of Supportive Oncology
David Green, MD, PhD, Associate Editor
- Nothing to disclose
-
David H. Ilson, MD, PhD, Associate Editor
- Speaker's bureau
-
- Amgen; Genentech; Inclone; Pfizer; sanofi-aventis
- Grant / research support
-
- Bristol-Myers Squibb; Genentech; sanofi-aventis
Henry Mark Kuerer, MD, PhD, FACS, Associate Editor
- Speaker's bureau
-
- Physician Education Resource
- Grant / research support
-
- Genentec
- Editorial boards
-
- Annals of Surgical Oncology; Breast Disease Quarterly; Cancer Journal; Journal of Clinical Oncology
- Leadership positions in professional societies
-
- Society of Surgical Oncology (Program Chair)
Barbara A. Murphy, MD, Associate Editor
- Consultant / Advisory board
-
- Bristol-Myers Squibb; MedImmune
- Speaker's bureau
-
- Amgen; Bristol-Myers Squibb
- Grant / research support
-
- MedImmune
- Editorial boards
-
- Journal of Supportive Oncology
- Leadership positions in professional societies
-
- Eastern Cooperative Oncology Group (Chair for Head and Neck Cancer)
Michael E. Williams, MD, Associate Editor
- Consultant / Advisory board
-
- Celgene
- Speaker's bureau
-
- Biogen IDEC; Educational Concepts Group; Genentech; Health Science Communications
- Grant / research support
-
- Lymphoma Research Foundation; Cephalon; Genentech
- Editorial boards
-
- Modern Pathology; The Hematologist
- Leadership positions in professional societies
-
- American Society of Hematology (Chair, Educational Affairs Committee); Lymphoma Research Foundation (Chair, Mantle Cell Lymphoma Consortium and Member, Scientific Advisory Board)
Editors who have left the board since January 2007
Manuel Hidalgo, MD, PhD, Associate Editor 2006-2008
- Consultant / Advisory board
-
- Amgen; AstraZeneca
- Grant / research support
-
- AstraZeneca; EISAI; RayBiotech; Wyeth
- Editorial boards
-
- Molecular Cancer Therapeutics
This information reflects Dr. Hidalgo's annual report of disclosable interests at the time he was last affiliated with Journal Watch, in 2008.
Mark A. Socinski, MD, Associate Editor 2006–2007
- Consultant / Advisory board
-
- Genentech; Eli Lilly
- Speaker's bureau
-
- Amgen; Genentech; Eli Lilly; sanofi-aventis
- Grant / research support
-
- Genentech; Eli Lilly; Pfizer; sanofi-aventis
- Editorial boards
-
- Journal of Clinical Oncology
This information reflects Dr. Socinski's annual report of disclosable interests at the time he was last affiliated with Journal Watch, in 2007.